Jennifer Kan
Member at Global Women in Investor
San Diego, California
Overview
Work Experience
Managing Partner at Climate Capital Bio
2022 - Current
Backing biotech and frontier technology founders building climate solutions.
Climate Capital is an investment firm that supports companies that directly or indirectly reduce global greenhouse gas emissions.
Member
2022
Advisor
2022 - 2022
Co-Founder & President
2020 - 2021
- Co-founded a venture-backed health tech startup that helps care and medical facilities hire healthcare professionals - Founding business development lead - Completed YC Build Sprint (Winter 2021) and Stanford Rebuild (2020)
Senior Sustainable Investing Fellow
2022 - 2022
Built bridges between financial assets and impact opportunities via advisory and asset management services. Designed financial products and built ecosystems for underrepresented entrepreneurs.
17 Asset Management manages financial solutions, product design and distribution services to investors, corporate clients & asset managers.
Scientific and Technical Consultant
2019 - 2021
Expert consultant to biotech, medtech, and chemical startups, companies, university technology transfer offices, and funding organizations.
Scientific Consultant
2019 - 2020
Enzyme technology consultant and product launch speaker for Lancôme.
Postdoctoral Scholar
2015 - 2019
- Lead protein engineer in the laboratory of Frances H. Arnold (2018 Nobel Laureate in Chemistry) - Published 12 peer-reviewed publications on protein engineering and synthetic biology (inc. 2 first-authored Science and Nature papers). Inventor of 6 patents. - Raised $1.4M in grants and awards from government, foundations, and enterprises for research and technology transfer projects - Worked with startups and Fortune 500 companies to use biology to solve problems and launch products. - Invited speaker at Stanford, UC Berkeley, MIT, Cambridge
Helmsley Fellow in Synthetic Biology
2017 - 2017
Research Fellow
2012 - 2015
(2012-2014 on intermission)
JSPS Research Fellow
2012 - 2014